The Texas Heart Institute at Baylor College of Medicine Igor Palacios Symposium 2025

Target Audience This activity is designed for physicians, physician assistants, nurse practitioners, registered nurses, and other medical care providers who are interested in the latest advances in cardiology. Fellows, residents, and medical students are also welcome to attend. Educational Objectives At the conclusion of this activity, the participants should be able to: Evaluate recent advances in percutaneous treatments for congenital heart disease, including diagnostic innovations and evolving guideline-based strategies for ambulatory management. Analyze paradigm shifts in the treatment of acute heart failure, with emphasis on percutaneous techniques, surveillance strategies, and interdisciplinary approaches to care. Explore emerging applications of artificial intelligence in cardiology, recognizing current use cases, limitations, and future directions for clinical integration and decision support. Interpret evolving diagnostic and management strategies for valvular and congenital heart disease, including surveillance approaches, guideline updates, and the role of emerging technologies in structural heart interventions. Educational Methods Lecture • Case Study • Panel Discussion Evaluation Videos only no PDFS Target Audience: cardiologists, cardiologists with an interest in electrophysiology, cardiac electrophysiologists, cardiovascular surgeons, internists with an interest in cardiology list or videos Sr. No. Title Duration Speaker 1 Coronary Physiology in Ventricular Unloading 14:59 Carlos Davila 2 CTO PCI Case Review: Overcoming Complex RCA Occlusions 12:11 Ali Emin Denktas 3 Advanced Calcium Modification in Complex RCA Disease: OCT-Guided Rotational Atherectomy and IVL 15:03 Pedro Moreno 4 Diagnosing CAD in Intermediate-Risk Patients: The Role of CTTA FFRCT 22:06 Ismael Lopez 5 New Devices for Cardiogenic Shock 12:34 Robert Yeh 6 Mechanical Cardiocirculatory Support in Structural Heart 13:38 Gennaro Giustino 7 On the Shoulders of Our Mentors 19:01 Jeff Popma 8 Aortic Valve Replacement in Patients with Severe Asymptomatic Aortic Stenosis 14:41 Angel Caldera 9 Advancements in Treatment for Aortic Regurgitation 13:22 Vinod Thourani 10 New TAVR Devices 13:48 Sachin Goel 11 Role of Minimally Invasive (Robotic) Surgery in Treating MV Regurgitation 17:13 Kenneth Liao 12 Complex M-TEER / Ischemic MR 10:56 Sachin Goel 13 The Journey for the Tendyne Valve Approval for MAC 18:00 Eduardo De Marchena 14 New Transcatheter Mitral Valve Replacement Platforms: Edwards Sapien M3 11:52 Ignacio Inglessis-Azuaje 15 Continuing Advances and Challenges of Valvular Heart Disease Intervention in the Next Decade 44:15 Igor Palacios 16 Improving Care in Aortic Stenosis: A Mandate for Change 22:51 Jonathan Passeri 17 Artificial Intelligence in Structural Heart Disease to Improve Access 13:01 Pablo Rengifo-Moreno 18 Boots on the Ground Are Needed for Change 06:35 Caitlin Reen 19 Best Practices for MCS for AMICS 28:23 William O’Neill 20 Beyond the Murmur: Surveillance Strategies for Aortic Stenosis in a Changing Landscape 22:44 Misty Theriot 21 First Do No Harm: The Science Behind Our Recommendations for Weight Loss 24:41 Catharine Wetzel 22 Updates in Atrial Fibrillation in Structural Heart Disease 13:17 Audrey Nicholson 23 Ambulatory Management of Heart Failure: Guideline Updates & Optimization Strategies 28:34 Nicole Dellise 24 Decoding Genetic Aortopathies: Diagnosis, Management, and Guidelines 20:00 Brittany Rhoades